Neuroinflammation: Microglial activation during sepsis

Current Neurovascular Research

Volumn 11, Issue 3, 2014, Pages 263-270

  Michels, Monique ^a   Danielski, Lucinéia G ^a   Dal Pizzol, Felipe ^a   Petronilho, Fabrícia ^a  

^a UNIVERSITY OF SOUTHERN SANTA CATARINA   (Brazil)

Author keywords

Blood brain barrier; CNS; Encephalopathy; Microglia; Neuroinflammation; Sepsis

Indexed keywords

GELATINASE B; INTERLEUKIN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; REACTIVE OXYGEN METABOLITE; STROMELYSIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN DYSFUNCTION; CYTOKINE RESPONSE; DISEASE ASSOCIATION; EXTRACELLULAR SPACE; GLIA CELL; HUMAN; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OLIGODENDROGLIA; PHAGOCYTOSIS; PRIORITY JOURNAL; SEPSIS;

EID: 84906852946     PISSN: 15672026     EISSN: 18755739     Source Type: Journal    
DOI: 10.2174/1567202611666140520122744     Document Type: Article

References (146)

1. Barichello T, Martins MR, Reinke A, et al. Cognitive impairment in sepsis survivors from cecal ligation and perforation. Crit Care Med 2005; 33(1): 221-3
2. Tuon L, Comim CM, Petronilho F, et al. Time-dependent behavioral recovery after sepsis in rats. Intensive Care Med 2008; 34(9): 1724-31
3. Fukuda B. Aquaporin 4: A player in cerebral edema and neuroinflammation. J Neuroinflammation 2012; 9: 279
4. Ransohoff RM, Perry VH. Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 2009; 27; 119-45
5. Streit WJ, Conde JR, Fendrick SE, Flanary BE, Mariani CL. Role of microglia in the central nervous system's immune response. Neurol Res 2005; 27(7): 685-91
6. Shatz CJ. MHC Class I: An unexpected role in neuronal plasticity. Neuron 2009; 64(1): 40-5
7. Hawkins BT, Davis TP. The Blood-Brain Barrier/Neurovascular Unit in Health and Disease. Pharmacol Rev 2005; 57(2): 173-85
8. Liu W, Tang Y, Feng J. Cross talk between activation of microglia and astrocytes in pathological conditions in the central nervous system. Life Sci 2011; 89(5-6): 141-6
9. Van der Putten C, Zuiderwijk-Sick E, Van Straalen L, et al. Differential expression of adenosine A3 receptors controls adenosine A2A receptor-mediated inhibition of TLR responses in microglia. J Immunol 2009; 182(12): 7603-12
10. Puntambekar SS, Doose JM, Carson MJ. Microglia: A CNSSpecific Tissue Macrophage. Central Nervous System Diseases and Inflammation 2008; 1-12
11. McGeer EG, McGeer PL. Neuroinflammation. Alzheimer Disease, and other aging disorders. In: Cuello AC: Pharmacological Mechanisms in Alzheimer's Disease. 2nd Ed. Springer, New York: 2008; pp. 149-66
12. Kreutzberg GW. Microglia: A sensor for pathological events in the CNS. Trends Neurosci 1996; 19(8): 312-8
13. Liang J, Takeuchi H, Jin S, et al. Glutamate induces neurotrophic factor productionfrom microglia via protein kinase C pathway. Brain Res 2010; 1322: 8-23
14. Polazzi E, Gianni T, Contestabile A. Microglial cells protect cerebellar granule neurons from apoptosis: Evidence for reciprocal signaling. Glia 2001; 36(3): 271-80
15. Polazzi, E, Contestabile A. Overactivation of LPS-stimulated microglial cells by co-cultured neurons or neuron-conditioned medium. J Neuroimmunol 2006; 172(1-2): 104-11
16. Lawson LJ, Perry V, Dri PH, Gordon S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 1990; 39(1): 151-70
17. Davoust N, Vuaillat C, Androdias G, Nataf S. From bone marrow to microglia: barriers and avenues. Trends Immunol 2008; 29(5): 227-34
18. Kida S, Steart PV, Zhang ET, Weller RO. Perivascular cells act as scavengers in the cerebral perivascular spaces and remain distinct from pericytes, microglia and macrophages. Acta Neuropathol 1993; 85(6): 646-52
19. Adams RA, Bauer J, Flick MJ, et al. The fibrin-derived g377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease. J Exp Med 2007; 204(3): 571-82
20. Binstadt BA, Patel PR, Alencar H, et al. Particularities of the vasculature can promote the organ specificity of autoimmune attack. Nat Immunol 2006; 7(3): 284-92
21. de Haas AH, Boddeke HW, Biber K. Region-specific expression of immunoregulatory proteins on microglia in the healthy CNS. Glia 2008; 56(8): 888-94
22. Perry VH, Crocker PR, Gordon S. The blood-brain barrier regulates the expression of a macrophage sialic acid-binding receptor on microglia. J Cell Sci 1992; 101(Pt1): 201-07
23. Ransohoff RM, Perry VH. Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 2009; 27: 119-45
24. Long-Smith CM, Sullivan AM, Nolan YM. The influence of microglia on the pathogenesis of Parkinson's disease. Prog Neurobiol 2009; 89(3): 277-87
25. Davalos D, Grutzendler J, Yang G, et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci 2005; 8(6): 752-8
26. Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005; 308(5726): 1314-8
27. Town T, Nikolic V, Tan J. The microglial "activation" continuum: from innate to adaptive responses. J neuroinflammation 2005; 2: 24
28. Ladeby R, Wirenfeldt M, Dalmau I, et al. Proliferating resident microglia express the stem cell antigen CD34 in response to acute neural injury. Glia 2005b; 50(2): 121-31
29. Ajami B, Bennett JL, Krieger C, Tetzlaff W, Rossi FM. Local selfrenewal can sustain CNS microglia maintenance and function throughout adult life. Nat Neurosci 2007; 10(12): 1538-43
30. Abbott NJ, Romero IA. Transporting therapeutics across the bloodbrain barrier. Mol Med Today 1996; 2(3): 106-13
31. Perry VH, Anthony DC, Bolton SJ, Brown HC. The blood-brain barrier an the inflammatory response. Mol Med Today 1997; 3(8): 335-41
32. Janzer RC, Raff MC. Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 1997; 325(6101): 253-7
33. Ballabh P, Braun A, Nedergaard M. The blood-brain barrier: An overview Structure, regulation, and clinical implications. Neurobiol Dis 2004; 16(1): 1-13
34. Rosell A, Ortega-Aznar A, Alvarez-Sabin J, et al. Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke. Stroke 2006; 37(6): 1399-406
35. Rosenberg GA, Estrada EY, Dencoff JE. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 1998; 29(10): 2189-95
36. Candelario-Jalil E, Yang Y, Rosenberg GA. Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. Neuroscience 2009; 158(3): 983-94
37. Nishino A, Suzuki M, Ohtani H, et al. Thrombin may contribute to the pathophysiology of central nervous system injury. J Neurotrauma 1993; 10(2): 167-79
38. Ryu JK, Davalos D, Akassoglou K. Fibrinogen signal transduction in the nervous system. J Thromb Haemost 2009; 7(Suppl 1): 151-4
39. Donnelly DJ, Popovich PG. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol 2008; 209(2): 378-88
40. Merrill JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 1993; 151(4): 2132-41
41. Kawano H, Kimura-Kuroda J, Komuta Y, et al. Role of the lesion scar in the response to damage and repair of the central nervous system. Cell Tissue Res 2012; 349(1): 169-80
42. Rolls A, Shechter R, Schwartz M. The bright side of the glial scar in CNS repair. Nat Rev Neurosci 2009; 10(3): 235-41
43. Young CB, Bolton CF, Archibald YM, Austin TW, Wells GA. The electroencephalogram in sepsis-Associated encephalopathy. J Clin Neurophysiol 1992; 9(1): 145-52
44. Bowton DL, Bertels NH, Prough DS, Stump DA. Cerebral blood flow is reduced in patients with sepsis syndrome. Crit Care Med 1989; 17(5): 399-403
45. Maekawa T, Fujii Y, Sadamitsu D, et al. Cerebral circulation and metabolism in patients with septic encephalopathy. Am J Emerg Med 1991; 9(2): 139-143
46. Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischaemia - The ischaemic penumbra. Stroke 1981; 12(6): 723-5
47. Hossman KA. Viability thresholds and the penumbra of focal ischemia. Ann Neurol 1994; 36(4): 557-65
48. Goris RJ. Mediators of multiple organ failure. Intensive Care Med 1990; 16(Suppl3): S192-6
49. Landis DMD. Brain as a tissue: The interacting cell populations of the central nervous system. In: Ransohoff RM, Benveniste EN, Eds. Cytokines and the CNS. Boca Raton: CRC Press 1996; 63-83
50. Aldskogius H. Microglia in neuroregeneration. Microsc Res Tech 2001; 54(1): 40-6
51. Prewitt CM, Niesman IR, Kane CJ, Houle JD. Activated macrophage microglial cells can promote the regeneration of sensory axons into the injured spinal cord. Exp Neurol 1997; 148(2): 433-43
52. Rabchevsky AG, Streit WJ. Grafting of cultured microglial cells into the lesioned spinal cord of adult rats enhances neurite outgrowth. J Neurosci Res 1997; 47(1): 34-48
53. Moller JC, Klein MA, Haas S, Jones LL, Kreutzberg GW, Raivich, G. Regulation of thrombospondin in the regenerating mouse facial motor nucleus. Glia 1996; 17(2): 121-32
54. Gaudet DA, Popovich PG, Ramer MS. Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury. J Neuroinflammation 2011; 8:110
55. Hirschberg DL, Schwartz M. Macrophage recruitment to acutely injured central nervous system is inhibited by a resident factor: A basis for an immunebrain barrier. J Neuroimmunol 1995; 61(1): 89-96
56. Lazarov-Spiegler O, Rapalino O, Agranov G, Schwartz M. Restricted inflammatory reaction in the CNS: A key impediment to axonal regeneration? Mol Med Today 1998; 4(8):337-42
57. Lazarov-Spiegler O, Solomon AS, Zeev-Brann AB, Hirschberg DL, Lavie V, Schwartz M. Transplantation of activated macrophages overcomes central nervous system regrowth failure. FASEB J 1996; 10(11):1296-302
58. Zeev-Brann AB, Lazarov-Spiegler O, Brenner T, Schwartz M. Differential effects of central and peripheral nerves on macrophages and microglia. Glia 1998; 23(3):181-90
59. Rapalino O, Lazarov-Spiegler O, Agranov E, et al. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat Med 1998; 4: 814-21
60. Schartner JM, Hagar AR, Van Handel M, Zhang L, Nadkami N, Badie B. Impaired capacity for upregulation of MHC class II in tumor-Associated microglia. Glia 2005; 51(4):279-85
61. Dheen ST, Kaur C, Ling EA. Microglial activation and its implications in the brain diseases. Curr Med Chem 2007; 14(11):1189-97
62. Kiefer R, Streit WJ, Toyka KV, Kreutzberg GW, Hartung HP. Transforming growth factor-beta 1: A lesion-Associated cytokine of the nervous system. Int J Dev Neurosci 1995; 13(3-4):331-9
63. Kim BJ, Kim MJ, Park JM, et al. Reduced neurogenesis after suppressed inflammation by minocycline in transient cerebral ischemia in rat. J Neurol Sci 2009a; 279(1-2):70-5
64. Imai F, Suzuki H, Oda J, et al. Neuroprotective effect of exogenous microglia in global brain ischemia. J Cereb Blood Flow Metab 2007; 27(3):488-500
65. Lalancette-Hebert M, Gowing G, Simard A, Weng YC, Kriz J. Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J Neurosci 2007; 27(10): 2596-605
66. Lambertsen KL, Clausen BH, Babcock AA, et al. Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. J Neurosci 2009; 29(5):1319-930
67. Neumann J, Gunzer M, Gutzeit HO, Ullrich O, Reymann KG, Dinkel K. Microglia provide neuroprotection after ischemia. FASEB J 2006; 20(6):714-6
68. Madinier A, Bertrand N, Mossiat C, et al. Microglial involvement in neuroplastic changes following focal brain ischemia in rats. PLoS One 2009; 4(12):e8101
69. Streit WJ, Semple-Rowland SL, Hurley SD, Miller RC, Popovich PG, Stokes BT. Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis. Exp Neurol 1998; 152(1):74-87
70. Yanagisawa D, Kitamura Y, Takata K, Hide I, Nakata Y, Taniguchi T. Possible involvement of P2X7 receptor activation in microglial neuroprotection against focal cerebral ischemia in rats. Biol Pharm Bull 2008; 31(6):1121-30
71. Hickey WF, Kimura H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 1988; 239(4837): 290-2
72. McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 1988; 38(8): 1285-91
73. Garden GA, Moller T. Microglia biology in health and disease. J Neuroimmune Pharmacol 2006; 1(2): 127-37
74. Kettenmann H, Hanisch UK, Noda M, Verkhratsky A. Physiology of microglia. Physiol Rev 2011; 91(2): 461-553
75. Yoshioka N, Asou H, Hisanaga S, Kawano H. The astrocytic lineage marker calmodulin-regulated spectrin-Associated protein 1 (Camsap1): phenotypic heterogeneity of newly born Camsap1- expressing cells in injured mouse brain. J Comp Neurol (In press) 2012; 520(6):1301-17
76. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 2004; 4(3):181-9
77. Geiszt M, Leto TL. The Nox family of NAD(P)H oxidases: Host defense and beyond. J Biol Chem 2004; 279(50):51715-8
78. Halliwell B. Oxidative stress and neurodegeneration: Where are we now? J Neurochem 2006; 97(6):1634-58
79. Sumimoto H, Miyano K, Takeya R. Molecular composition and regulation of the Nox family NAD(P)H oxidases. Biochem Biophys Res Commun 2005; 338(1): 677-86
80. Goode HF, Cowley HC, Walker BE, Webster NR. Decreased antioxidant status and increased lipid peroxidation in patients with sepsis and secondary organ dysfunction. Crit Care Med 1995; 23(4): 646-51
81. Galley HF, Davies MJ, Webster NR. Xanthine oxidase activity and free radical generation in patients with sepsis syndrome. Crit Care Med 1996; 24(10): 1649-53
82. Cowley HC, Bacon PJ, Goode HF, Webster NR, Jones JG, Menon DK. Plasma antioxidant potential in sepsis: A comparison of survivors and non-survivors. Crit Care Med 1996; 24(7): 1179-83
83. Chuang CC, Shiesh SC, Chi CH, et al. Serum total antioxidant capacity reflects severity of illness in patients with severe sepsis. Crit Care 2006; 10(1): R36
84. Borrelli E, Roux-Lombard P, Grau GE, et al. Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med 1996; 24(3): 392-97
85. Cross CE, Forte T, Stocker R, et al. Oxidative stress and abnormal cholesterol metabolism in patients with adult respiratory distress syndrome. J Lab Clin Med 1990; 115(4): 396-404
86. Galley HF, Davies MJ, Webster NR. Ascorbyl radical formation in patients with sepsis: Effect of ascorbate loading. Free Radic Biol Med 1995; 20(1): 139-43
87. Heppner FL, Greter M, Marino D, et al. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat Med 2005; 11(2): 146-52
88. D'Aversa TG, Weidenheim KM, Berman JW. CD40-CD40L interactions induce chemokine expression by human microglia: implications for human immunodeficiency virus encephalitis and multiple sclerosis. Am J Pathol 2002; 160(2): 559-67
89. Olson JK., Girvin AM, Miller SD. Direct activation of innate and antigen-presenting functions of microglia following infection with Theiler's virus. J Virol 2001; 75(20): 9780-9
90. Tompkins SM. Padilla J, Dal Canto MC, Ting JP, Van Kaer L, Miller SD. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. J Immunol 2002; 168(8): 4173-83
91. Liiu L, Persson JK, Svensson M, Aldskogius H. Glial cell responses, complement, and clusterin in the central nervous system following dorsal root transection. Glia 1998; 23(3): 221-38
92. Kutsilieri E.,ter Meulen V, Riederer P, Gerlach M. Involment of microglia in cerebrospinal fluid glutamate increase in SIV-infected rhesus monkeys (Macaca mulatta). AIDS Res Hum Retroviruses 1999; 15(5): 471-7.
93. Chao CC, Hu S, Peterson PK. Modulation of human microglial cell superoxide production by cytokines. J Leukoc Biol 1995; 58(1): 65-70
94. Colton C, Wilt S, Gilbert D, Chernyshev O, Snell J, Dubois-Dalcq M. Species differences in the generation of reactive oxygen species by microglia. Mol Chem Neuropathol 1996; 28(1-3): 15-20
95. Marín-Teva JL, Dusart I, Colin C, Gervais A, van Rooijen N, Mallat M. Microglia promote the death of developing Purkinje cells. Neuron 2004; 41(4): 535-47
96. Henry CJ, Huang Y, Wynne A. Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. J Neuroinflammation 2008; 5: 15
97. Amin AR, Attur MG, Thakker GD. A novel mechanism of action of tetracyclines: Effects on nitric oxide synthases. Proc Natl Acad Sci USA 1996; 93(24):14014-9
98. Ekdahl CT, Claasen JH, Bonde S, Kokaia Z, Lindvall O. Inflammation is detrimental for neurogenesis in adult brain. Proc Natl Acad Sci USA 2003; 100(23):13632-7
99. Tomas-Camardiel M, Rite I, Herrera AJ. Minocycline reduces the lipopolysaccharideinduced inflammatory reaction, peroxynitritemediated nitration of proteins, disruption of the blood-brain barrier, and damage in the nigral dopaminergic system. Neurobiol Dis 2004; 16(1):190-201
100. Griffin R, Nally R, Nolan Y, McCartney Y, Linden J, Lynch MA. The age-related attenuation in long-term potentiation is associated with microglial activation. J Neurochem 2006; 99(4):1263-72
101. Nikodemova M, Duncan ID, Watters JJ. Minocycline exerts inhibitory effects on multiple mitogen-Activated protein kinases and IkappaBalpha degradation in a stimulus-specific manner in microglia. J Neurochem 2006; 96(2): 314-23
102. Polazzi E, Monti B. Microglia and neuroprotection: From in vitro studies to therapeutic applications. Prog Neurobiol 2010; 92(3): 293-315
103. Ransohoff, RM, Perry VH. Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 2009; 27:119-45
104. Kim JH, Park JA, Lee SW, Kim WJ, Yu YS, Kim KW. Bloodneural barrier: intercellular communication at glio-vascular interface. J Biochem Mol Biol 2006; 39(4): 339-45
105. Streit WJ, Graeber MB, Kreutzberg GW. Functional plasticity of microglia: A review. Glia1988; 1(5): 301-7
106. Bignami A. The role of astrocytes in CNS regeneration. J Neurosurg Sci 1984; 28(3-4): 127-32
107. Bouchard C, Pagé J, Bédard A, Tremblay P, Vallières L. G proteincoupled receptor 84, a microglia-Associated protein expressed in neuroinflammatory conditions. Glia 2007; 55(8): 790-800
108. Galiano M, Liu ZQ, Kalla R, et al. Interleukin-6 (IL6) and cellular response to facial nerve injury: Effects on lymphocyte recruitment, early microglial activation and axonal outgrowth in IL6-deficient mice. Eur J Neurosci 2001; 14(2): 327-41
109. Raivich G, Moreno-Flores MT, Müller JC, Kreutzberg GW. Regulation of microglial proliferation: colony-stimulating factors and their receptors. Neuropathol Appl Neurobiol 1994; 20(2): 209-11
110. Sheng JG, Mrak RE, Griffin WS. Enlarged and phagocytic, but not primed, interleukin-1 alpha-immunoreactive microglia increase with age in normal human brain. Acta Neuropathol 1998; 95(3): 229-34
111. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992.Chest 2009; 136(Suppl 5): E28
112. Andrades ME, Ritter C, Dal-Pizzol F. The role of free radicals in sepsis development. Front Biosci 2009; 1: 277-87
113. Billiau A, Vandekerckhove F. Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock. Eur J Clin Invest 1991; 21(6): 559-73
114. Calandra T, Baumgartner JD, Grau GE, et al. Prognosis values of tumor necrosis/cachectin, interleukin-1, alpha-interferon and gama interferon in the serum of pacients with septic shock. J Infect Dis 1990; 161(5): 982-7
115. Gutierrez-Ramos JC, Bluethmann H. Molecules and mechanisms operating in septic shock: lessons from Knockout mice. Immunol Today 1997; 18(7): 329-34
116. Waage A, Halstensen A, Espevik T. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987; 1(8529): 355-7
117. Li L, Zhang J, Yang Y. Single-wall carbon nanohorns inhibited activation of microglia induced by lipopolysaccharide through blocking of Sirt3. Nanoscale Res Lett 2013; 8(1): 100
118. Semmler A, Widmann CN, Okulla T. Persistent cognitive impairment, hippocampal atrophy and EEG changes in sepsis survivors. J Neurol Neurosurg Psychiatry 2013; 84(1): 62-9
119. Terrando N, Fidalgo AR, Vizcaychipi M. The impact of IL-1 modulation on the development of lipopolysaccharide-induced cognitive dysfunction. Crit Care 2010; 14(3): R88
120. Hoshino K, Takeuchi O, Kawai T, et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the Lps gene product. J Immunol 1999; 162(7): 3749-52
121. Kadhim H, Tabarki B, De Prez C, Rona AM, Sebire G. Interleukin- 2 in the pathogenesis of perinatal white matter damage. Neurology 2002; 58(7): 1125-8
122. Lehnardt S, Massillon L, Follett P, et al. Activation of innate immunity in the CNS triggers neurodegeneration through a Tolllike receptor 4-dependent pathway. Proc Natl Acad Sci USA 2003; 100(14): 8514-9
123. Andreakos E, Sacre SM, Smith C, et al. Distinct pathways of LPSinduced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP. Blood 2004; 103(6): 2229-37
124. Van Dam AM, Brouns M, Man AHW, Berkenbosch F. Immunocytochemical detection of prostaglandin E2 in microvasculature and in neurons of rat brain after administration of bacterial endotoxin. Brain Res 1993; 613(2): 331-6
125. Kacimi R, Giffard RG, Yenari MA. Endotoxin-Activated microglia injure brain derived endothelial cells via NF-KB, JAK-STAT and JNK stress kinase pathways. J Inflammation 2011; 8: 7
126. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996; 87(6): 2095-147
127. Murray CA, Lynch MA. Evidence that increased hippocampal expression of the cytokine interleukin-1 beta is a common trigger for age- and stress-induced impairments in long-term potentiation. J Neurosci. 1998; 18(8): 2974-81
128. Quan N, BanksWA. Brain-immune communication pathways. Brain Behav Immun 2007; 21(6): 727-35
129. Waage A, Halstensen A, Shalaby R, Brandtzaeg P, Kierulf P, Espevik T. Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response. J Exp Med 1989; 170(6): 1859-67
130. Rachal Pugh C, Fleshner M,Watkins LR, Maier SF, Rudy JW. The immune system and memory consolidation: A role for the cytokine IL-1beta. Neurosci Biobehav Rev 2001; 25(1): 29-41
131. Shieh JH, Peterson RH, Moore MA. IL-1 modulation of cytokine receptors on bone marrow cells. In vitro and in vivo studies. J Immunol 1991; 147(4): 1273-8
132. McGrane S, Girard TD, Thompson JL, et al. Procalcitonin and Creactive protein levels at admission as predictors of duration of acute brain dysfunction in critically ill patients. Crit Care 2011; 15(2): R78
133. van den Boogaard M, Kox M, Quinn KL, et al. Biomarkers associated with delirium in critically ill patients and their relation with longterm subjective cognitive dysfunction; indications for different pathways governing delirium in inflamed and noninflammed patients. Crit Care 2011; 15(6): R297
134. Murray CA, Lynch MA. Evidence that increased hippocampal expression of the cytokine interleukin-1 beta is a common trigger for age- and stress-induced impairments in long-term potentiation. J Neurosci 1998; 18(8): 2974-81
135. Semmler A, Okulla T, Sastre M, Dumitrescu-Ozimek L, Heneka MT. Systemic inflammation induces apoptosis with variable vulnerability of different brain regions. J Chem Neuroanat 2005; 30(2-3): 144-57
136. Ock J, Jeong J, Choi WS, et al. Regulation of Tolllike receptor 4 expression and its signaling by hypoxia in cultured microglia. J Neurosci Res 2007; 85(9): 1989-95
137. Yao L, Kan EM, Lu J, et al. Toll-like receptor 4 mediates microglial activation and production of inflammatory mediators in neonatal rat brain following hypoxia: role of TLR4 in hypoxic microglia. J Neuroinflammation 2013; 10: 23
138. Kaur C, Rathnasamy G, Ling EA. Roles of activated microglia in hypoxia induced neuroinflammation in the developing brain and the retina. J Neuroimmune Pharmacol 2013; 8(1): 66-78
139. Boehme M, Guenther M, Stahr A, et al. Impact of indomethacin on neuroinflammation and hippocampal neurogenesis in aged mice. Neurosci Lett 2014; 14: S0304-3940
140. Taccone FS, Castanares-Zapatero D, Peres-Bota D, Vincent JL, Berre J, Melot C. Cerebral autoregulation is influenced by carbon dioxide levels in patients with septic shock. Neurocrit Care 2010; 3: 35-42
141. Kaur C, Ling EA. Periventricular white matter damage in the hypoxic neonatal brain: role of microglial cells. Prog Neurobiol 2009; 87(4): 264-80
142. Naito Y, Yoshioka K, Tanaka K, Tatsumi K, Kimura S, Kasuya Y. Endothelin B receptor-mediated encephalopathic events in mouse sepsis model. Life Sci 2014; 14: S0024-3205
143. Pittet JF, Morel DR, Hemsen A, et al. Elevated plasma endothelin- 1 concentrations are associated with the severity of illness in patients with sepsis. Ann Surg 1991; 213: 261-4
144. Eakes AT, Howard KM, Miller JE, Olson MS. Endothelin-1 production by hepatic endothelial cells: characterization and augmentation by endotoxin exposure. Am J Physiol 1997; 272: G605-11
145. Yuan TM, Sun Y, Zhan CY, Yu HM. Intrauterine infection/inflammation and perinatal brain damage: role of glial cells and toll-like receptor signaling. J Neuroimmunol 2010; 229: 16-25
146. Sharshar T, Polito A, Checinski A, Stevens RD. Septic-Associated encephalopathy - everything starts at a microlevel. Crit Care 2010; 14: 199.